Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Turner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Toxicologic Pathology|March 3, 2021
HistoNet: A Deep Learning-Based Model of Normal HistologyHolger Hoefling, Tobias Sing, Imtiaz Hossain, et al.
Organic Letters|October 21, 2024
Access to 2-Oxabicyclo[2.1.1]hexanes and their use in Scaffold HoppingOlivier Lorthioir, Niall Anderson, Scott Boyd, et al.
Bjpsych Open|March 3, 2020
Structured Psychological Support for people with personality disorder: feasibility randomised controlled trial of a low-intensity interventionMike J Crawford, Lavanya Thana, Jennie Parker, et al.
Toxicology and Applied Pharmacology|September 1, 2016
Ocular toxicity of AUY922 in pigmented and albino ratsDanielle Roman, James VerHoeve, Heiko Schadt, et al.
Toxicologic Pathology|June 3, 2022
Scientific and Regulatory Policy Committee Points to Consider: Primary Digital Histopathology Evaluation and Peer Review for Good Laboratory Practice (GLP) Nonclinical Toxicology StudiesThomas Forest, Famke Aeffner, Dinesh S Bangari, et al.
Science Translational Medicine|February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse eventsAnette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Molecular Therapy. Methods & Clinical Development|July 23, 2015
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout miceVivian W Choi, Chad E Bigelow, Terri L McGee, et al.
Toxicologic Pathology|June 14, 2011
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelinesFrank D Sistare, Daniel Morton, Carl Alden, et al.
Journal of Medicinal Chemistry|July 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA CooperativityJames M Smith, Bernard Barlaam, David Beattie, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Toxicologic Pathology|March 3, 2021
HistoNet: A Deep Learning-Based Model of Normal HistologyHolger Hoefling, Tobias Sing, Imtiaz Hossain, et al.
Organic Letters|October 21, 2024
Access to 2-Oxabicyclo[2.1.1]hexanes and their use in Scaffold HoppingOlivier Lorthioir, Niall Anderson, Scott Boyd, et al.
Bjpsych Open|March 3, 2020
Structured Psychological Support for people with personality disorder: feasibility randomised controlled trial of a low-intensity interventionMike J Crawford, Lavanya Thana, Jennie Parker, et al.
Toxicology and Applied Pharmacology|September 1, 2016
Ocular toxicity of AUY922 in pigmented and albino ratsDanielle Roman, James VerHoeve, Heiko Schadt, et al.
Toxicologic Pathology|June 3, 2022
Scientific and Regulatory Policy Committee Points to Consider: Primary Digital Histopathology Evaluation and Peer Review for Good Laboratory Practice (GLP) Nonclinical Toxicology StudiesThomas Forest, Famke Aeffner, Dinesh S Bangari, et al.
Science Translational Medicine|February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse eventsAnette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Molecular Therapy. Methods & Clinical Development|July 23, 2015
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout miceVivian W Choi, Chad E Bigelow, Terri L McGee, et al.
Toxicologic Pathology|June 14, 2011
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelinesFrank D Sistare, Daniel Morton, Carl Alden, et al.
Journal of Medicinal Chemistry|July 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA CooperativityJames M Smith, Bernard Barlaam, David Beattie, et al.
Pageof 2